Trials in Los Angeles, California
Here are the top 10 medical studies for lung cancer in Los Angeles, California
Popular Filters
Phase 3 Trials
Immunostimulant
Combination Immunotherapy for Lung Cancer
Recruiting1 awardPhase 2 & 3
Los Angeles, California
This trial is testing a new combination of treatments for patients with advanced lung cancer. The treatments aim to boost the immune system's ability to fight cancer and prevent it from growing. The goal is to see if this combination can help patients live longer compared to standard treatments.
Monoclonal Antibodies
Trastuzumab Deruxtecan for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Los Angeles, California
This trial will compare the effectiveness and safety of Trastuzumab Deruxtecan to the current standard of care for treating non-small cell lung cancer with HER2 Exon 19 or 20 mutations.
Monoclonal Antibodies
Dato-DXd + Pembrolizumab for Advanced Lung Cancer
Recruiting2 awardsPhase 3
Los Angeles, California
This trial will compare the effectiveness of a new cancer drug, datopotamab deruxtecan, when used with pembrolizumab versus pembrolizumab alone in patients with advanced lung cancer.
Trials With No Placebo
Chemotherapy
NX-1607 for Advanced Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing NX-1607, a new experimental drug, in adults with advanced cancers that don't respond to standard treatments. The goal is to see if NX-1607 can safely stop or reduce cancer growth, either by itself or with another drug called paclitaxel. Paclitaxel is a widely used anti-cancer drug for treating various types of solid malignant tumors including breast, ovarian, and lung cancers.
Tyrosine Kinase Inhibitor
BAY2927088 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is testing a new drug called BAY2927088 for people with advanced lung cancer. The drug aims to block certain proteins that help cancer grow. Researchers want to find out how safe the drug is, the best dose to use, and how well it works in stopping cancer.
Immunostimulant
Combination Immunotherapy for Lung Cancer
Recruiting1 awardPhase 2 & 3
Los Angeles, California
This trial is testing a new combination of treatments for patients with advanced lung cancer. The treatments aim to boost the immune system's ability to fight cancer and prevent it from growing. The goal is to see if this combination can help patients live longer compared to standard treatments.
Checkpoint Inhibitor
TransCon IL-2 β/γ + Pembrolizumab/Chemotherapy for Solid Tumor Cancers
Recruiting1 awardPhase 1 & 2
Los Angeles, California
This trial is testing a new drug called TransCon IL-2 β/γ for adults with advanced or spreading solid tumors. The drug aims to boost the immune system to better fight cancer by slowly releasing a molecule that helps immune cells attack cancer cells. TransCon IL-2 β/γ is a new long-acting drug currently being evaluated.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.